FDCDDQ
VKTX icon

Federation des caisses Desjardins du Quebec’s Viking Therapeutics VKTX Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$340K Buy
8,708
+25
+0.3% +$808 ﹤0.01% 1476
2026
Q1 		$283K Sell
8,683
-652
-7% -$21K ﹤0.01% 1446
2025
Q4 		$328K Sell
9,335
-355
-4% -$12.6K ﹤0.01% 1406
2025
Q3 		$255K Sell
9,690
-4,222
-30% -$126K ﹤0.01% 1426
2025
Q2 		$369K Buy
13,912
+494
+4% +$13K ﹤0.01% 1095
2025
Q1 		$324K Buy
13,418
+1,758
+15% +$55.6K ﹤0.01% 1084
2024
Q4 		$469K Sell
11,660
-4,050
-26% -$231K ﹤0.01% 977
2024
Q3 		$995K Buy
15,710
+6,800
+76% +$399K ﹤0.01% 786
2024
Q2 		$472K Buy
8,910
+3,650
+69% +$239K ﹤0.01% 953
2024
Q1 		$431K Buy
+5,260
New +$234K ﹤0.01% 915

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's VKTX Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec increased its Viking Therapeutics (VKTX) stake by 0.29% in Q2 2026, buying an estimated $808 and bringing the position to 8,708 shares worth $340K. The position accounts for ﹤0.01% of the portfolio, ranked #1476.

Federation des caisses Desjardins du Quebec first reported a position in VKTX in Q1 2024 and has held it in 10 quarters since. The position peaked at $995K in Q3 2024. 432 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Federation des caisses Desjardins du Quebec held 8,708 shares of Viking Therapeutics worth $340K as of Q2 2026.
  • Federation des caisses Desjardins du Quebec bought 25 Viking Therapeutics shares in Q2 2026, an estimated $808.
  • Viking Therapeutics made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #1476 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in Viking Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • Federation des caisses Desjardins du Quebec's Viking Therapeutics position peaked at $995K in Q3 2024.
  • 432 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.